Compile Data Set for Download or QSAR
maximum 50k data
Found 162 with Last Name = 'pasternack' and Initial = 'r'
TargetCoagulation factor XIII A/B chain(Human)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  4nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII B chain(Rabbit)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  7nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Rat)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  8nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM50245478(CHEMBL4081588 | US11472838, Compound Ref. 25)
Affinity DataIC50: >10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577509(US11472838, Compound 27 | US11472838, Compound 31a...)
Affinity DataIC50:  10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577537(US11472838, Compound Ref. 14)
Affinity DataIC50: >10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A/B chain(Human)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577540(US11472838, Compound Ref. 16)
Affinity DataIC50: >10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577546(US11472838, Compound Ref. 21)
Affinity DataIC50: >10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577484(US11472838, Compound 1a/b)
Affinity DataIC50:  11nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577511(US11472838, Compound 29 | US11472838, Compound 32a...)
Affinity DataIC50:  12nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577488(US11472838, Compound 6)
Affinity DataIC50:  12nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577487(US11472838, Compound 4)
Affinity DataIC50:  13nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577487(US11472838, Compound 4)
Affinity DataIC50:  14nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Mouse)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  15nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Crab-eating macaque)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  15nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577512(US11472838, Compound 30)
Affinity DataIC50:  15nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577485(US11472838, Compound 2a/b)
Affinity DataIC50:  16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577486(US11472838, Compound 3)
Affinity DataIC50:  16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Pig)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  16nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577512(US11472838, Compound 30)
Affinity DataIC50:  16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 6(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  17nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Rat)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  17nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577488(US11472838, Compound 6)
Affinity DataIC50:  17nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577506(US11472838, Compound 24a/b)
Affinity DataIC50:  18nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Mouse)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  19nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Crab-eating macaque)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  19nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577486(US11472838, Compound 3)
Affinity DataIC50:  20nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577507(US11472838, Compound 25a/b)
Affinity DataIC50:  20nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII B chain(Rabbit)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  20nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577490(US11472838, Compound 8a/b)
Affinity DataIC50:  21nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577489(US11472838, Compound 7a/b)
Affinity DataIC50:  21nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Dog)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577511(US11472838, Compound 29 | US11472838, Compound 32a...)
Affinity DataIC50:  24nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577496(US11472838, Compound 14a/b)
Affinity DataIC50:  26nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577529(US11472838, Compound Ref. 09)
Affinity DataIC50:  26nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577509(US11472838, Compound 27 | US11472838, Compound 31a...)
Affinity DataIC50:  27nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577509(US11472838, Compound 27 | US11472838, Compound 31a...)
Affinity DataIC50:  27nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Dog)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50:  28nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577511(US11472838, Compound 29 | US11472838, Compound 32a...)
Affinity DataIC50:  32nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577526(US11472838, Compound Ref. 7)
Affinity DataIC50:  32nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577547(US11472838, Compound 45a/b)
Affinity DataIC50:  35nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577507(US11472838, Compound 25a/b)
Affinity DataIC50:  35nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XIII A chain(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577510(US11472838, Compound 28)
Affinity DataIC50:  36nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577527(US11472838, Compound Ref. 08)
Affinity DataIC50:  36nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-glutamine gamma-glutamyltransferase 2(Homo sapiens (Human))
Zedira

US Patent
LigandPNGBDBM577492(US11472838, Compound 10a/b)
Affinity DataIC50:  38nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 162 total ) | Next | Last >>
Jump to: